442. Deputy Alan Kelly asked the Minister for Health the volume of uptake of biosimilar prescribing under the best value biologic process by the HSE to date in 2019; the number of patients prescribed biosimilars by treatment type to date in 2019; the average savings per patient compared to the originator drugs; and if he will make a statement on the matter. [44252/19]

Summary

442. Deputy Alan Kelly asked the Minister for Health the volume of uptake of biosimilar prescribing under the best value biologic process by the HSE to date in 2019; the number of patients prescribed biosimilars by treatment type to date in 2019; the average savings per patient compared to the originator drugs; and if he will make a statement on the matter. [44252/19]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Generic Drugs Substitution

  xml · EN · 5 November 2019

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.